OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenic cell death in cancer: concept and therapeutic implications
Lorenzo Galluzzi, Oliver Kepp, Erik C. Hett, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 138

Photodynamic therapy combined with immunotherapy: Recent advances and future research directions
Marta Warszyńska, Paweł Repetowski, J. Dąbrowski
Coordination Chemistry Reviews (2023) Vol. 495, pp. 215350-215350
Open Access | Times Cited: 53

Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 39

Type I interferon and cancer
Peter Holíček, Emma Guilbaud, Vanessa Klapp, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 115-127
Open Access | Times Cited: 36

Towards targeting the breast cancer immune microenvironment
Michael A. Harris, Peter Savas, Balaji Virassamy, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 554-577
Closed Access | Times Cited: 22

Immunogenicity of ferroptosis in cancer: a matter of context?
Elena Catanzaro, Robin Demuynck, Faye Naessens, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 407-416
Closed Access | Times Cited: 15

Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma
Shengmei Wang, Qiuyan Guo, Rubing Xu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25

Apoptosis and eryptosis: similarities and differences
Anton Tkachenko
APOPTOSIS (2023) Vol. 29, Iss. 3-4, pp. 482-502
Closed Access | Times Cited: 25

Bridging the gaps in cancer photothermal therapy through the intersection of nanotechnology and cell membrane coating
Shumin Yang, Huachun Pan, Blassan P. George, et al.
Chemical Engineering Journal (2024) Vol. 484, pp. 149641-149641
Closed Access | Times Cited: 11

Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9

Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better
Jayalakshmi Thiruppathi, Veena Vijayan, In‐Kyu Park, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 7

Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma
Xin Li, Yu‐Fei Pan, Yibin Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 6

Research progress of copper-based metal–organic frameworks for cancer diagnosis and therapy
Xian Li, Zhifang Ma, Haozheng Wang, et al.
Coordination Chemistry Reviews (2024) Vol. 514, pp. 215943-215943
Closed Access | Times Cited: 6

Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 6

MXene-based mild potothermal therapy synergizes STING activation to enhance the efficacy of cancer vaccines post-cryoablation
Fu-ming Wang, Xiaodong Zhu, Qianwen Zhang, et al.
Chemical Engineering Journal (2025) Vol. 505, pp. 159311-159311
Closed Access

Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
Alessandra Cesano, Ryan C. Augustin, Luigi Barrea, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e008876-e008876
Open Access

STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access

Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access

Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 18

Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodrı́guez-Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17

Calreticulin P-domain-derived “Eat-me” peptides for enhancing liposomal uptake in dendritic cells
Kuo‐Ching Mei, Nagasri Thota, Pu-Sheng Wei, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123844-123844
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top